Walleye Capital
Overview
Walleye Capital is a global multi-strategy investment firm that integrates deep fundamental research, advanced quantitative methods, and artificial intelligence to generate alpha across markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aardark Therapeutics | May 2024 | Series C | - |
| Odyssey Therapeutics | Dec 2023 | Series C | Co-investor |
| Clear Street | Apr 2023 | Series B Extension | Co-investor |
| Gauzy | Mar 2023 | Convertible Debt | Co-investor |
| Odyssey Therapeutics | Oct 2022 | Series B | Co-investor |
Key People
Richard Nathan Kalich
Managing Director
Jonathan Brenner
Partner, Chief Strategy Officer
Alberto M. Cozzini
Portfolio Manager
Alex Rubino
Portfolio Manager
Alex Tang
Quant Portfolio Manager
Allen C.
Portfolio Manager
Andrew Kim
Portfolio Manager
Andrew Sklar
Portfolio Manager
Benjamin Iriarte
Portfolio Manager, Quant Strategies
Chao Lu
Portfolio Manager
Charles Taylor
Portfolio Manager
Curtis Kuznecov
Portfolio Manager
Daniel Gershenson
Portfolio Manager
Ed Lee
Portfolio Manager
Gale Giger
Senior Portfolio Manager
Jake Slater
Portfolio Manager - Quantic
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
